United Therapeutics (UTHR) Capital Leases (2009)
United Therapeutics' (UTHR) quarterly Capital Leases came in at $30.3 million in Q4 2009.
United Therapeutics (UTHR) Capital Leases (2009) Analysis & Trends
United Therapeutics has disclosed Capital Leases across 1 years of filings, most recently posting $30.3 million for Q4 2009.
- Capital Leases for Q4 2009 came in at $30.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2009 was $30.3 million (changed N/A YoY), and the FY2009 annual result was $30.3 million, changed N/A from the prior year.
- Capital Leases came in at $30.3 million for Q4 2009 at United Therapeutics.
- In the past five years, Capital Leases ranged from a high of $30.3 million in Q4 2009 to a low of $30.3 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 30.33 Mn |